Intravenous immunoglobulin: use in dermatology

Intravenous immunoglobulin: use in dermatology

A manufactured blood product derived from fractionated human plasma, intravenous immunoglobulin (i.v.Ig) contains supra-physiologic levels of IgG. i.v.Ig is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infections diseases. Uncontrolled clinical studies an...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Skin therapy letter 2004-05, Vol.9 (5), p.1-6
Hauptverfasser: Mydlarski, P R, Mittmann, N, Shear, N H
Format: Artikel
Sprache:eng
Schlagworte:
Humans
Immunoglobulins, Intravenous - therapeutic use
Skin Diseases - drug therapy
Skin Diseases - immunology
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 6
container_issue 5
container_start_page 1
container_title Skin therapy letter
container_volume 9
creator Mydlarski, P R
Mittmann, N
Shear, N H
description A manufactured blood product derived from fractionated human plasma, intravenous immunoglobulin (i.v.Ig) contains supra-physiologic levels of IgG. i.v.Ig is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infections diseases. Uncontrolled clinical studies and anecdotal case reports recommend its use in dermatology, but randomized clinical trials are lacking. In selecting the most appropriate i.v.Ig for the patient, convenience, efficacy, safety and tolerability of the different products should be considered. With several measures in place to ensure its safety, i.v.Ig offers new hope for the treatment of many severe dermatologic conditions.
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_proquest_miscellaneous_71923373</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>71923373</sourcerecordid><originalsourceid>FETCH-LOGICAL-p122t-d6afd8664bb703642cac658a2b3c5c268deae5bbc723a5216101d7f66a3f1c8f3</originalsourceid><addsrcrecordid>eNo1j0tLw0AURmeh2Fr9C5KVu8g8bxJ3UnwUCm50He48UiLziJmM0H9vwbo6m8Ph-y7ImnHKatW13Ypc5_xFqRSygyuyYopJ4EDX5GEXlxl_XEwlV2MIJaaDT7r4MT5WJbtqjJV1c8Al-XQ43pDLAX12t2duyOfL88f2rd6_v-62T_t6YpwvtQUcbAsgtW6oAMkNGlAtci2MMhxa69AprU3DBSrOgFFmmwEAxcBMO4gNuf_rTnP6Li4vfRizcd5jdKelfcM6LkQjTuLdWSw6ONtP8xhwPvb_D8UvvYRL8Q</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>71923373</pqid></control><display><type>article</type><title>Intravenous immunoglobulin: use in dermatology</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><creator>Mydlarski, P R ; Mittmann, N ; Shear, N H</creator><creatorcontrib>Mydlarski, P R ; Mittmann, N ; Shear, N H</creatorcontrib><description>A manufactured blood product derived from fractionated human plasma, intravenous immunoglobulin (i.v.Ig) contains supra-physiologic levels of IgG. i.v.Ig is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infections diseases. Uncontrolled clinical studies and anecdotal case reports recommend its use in dermatology, but randomized clinical trials are lacking. In selecting the most appropriate i.v.Ig for the patient, convenience, efficacy, safety and tolerability of the different products should be considered. With several measures in place to ensure its safety, i.v.Ig offers new hope for the treatment of many severe dermatologic conditions.</description><identifier>ISSN: 1201-5989</identifier><identifier>PMID: 15146260</identifier><language>eng</language><publisher>Canada</publisher><subject>Humans ; Immunoglobulins, Intravenous - therapeutic use ; Skin Diseases - drug therapy ; Skin Diseases - immunology</subject><ispartof>Skin therapy letter, 2004-05, Vol.9 (5), p.1-6</ispartof><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/15146260$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mydlarski, P R</creatorcontrib><creatorcontrib>Mittmann, N</creatorcontrib><creatorcontrib>Shear, N H</creatorcontrib><title>Intravenous immunoglobulin: use in dermatology</title><title>Skin therapy letter</title><addtitle>Skin Therapy Lett</addtitle><description>A manufactured blood product derived from fractionated human plasma, intravenous immunoglobulin (i.v.Ig) contains supra-physiologic levels of IgG. i.v.Ig is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infections diseases. Uncontrolled clinical studies and anecdotal case reports recommend its use in dermatology, but randomized clinical trials are lacking. In selecting the most appropriate i.v.Ig for the patient, convenience, efficacy, safety and tolerability of the different products should be considered. With several measures in place to ensure its safety, i.v.Ig offers new hope for the treatment of many severe dermatologic conditions.</description><subject>Humans</subject><subject>Immunoglobulins, Intravenous - therapeutic use</subject><subject>Skin Diseases - drug therapy</subject><subject>Skin Diseases - immunology</subject><issn>1201-5989</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2004</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo1j0tLw0AURmeh2Fr9C5KVu8g8bxJ3UnwUCm50He48UiLziJmM0H9vwbo6m8Ph-y7ImnHKatW13Ypc5_xFqRSygyuyYopJ4EDX5GEXlxl_XEwlV2MIJaaDT7r4MT5WJbtqjJV1c8Al-XQ43pDLAX12t2duyOfL88f2rd6_v-62T_t6YpwvtQUcbAsgtW6oAMkNGlAtci2MMhxa69AprU3DBSrOgFFmmwEAxcBMO4gNuf_rTnP6Li4vfRizcd5jdKelfcM6LkQjTuLdWSw6ONtP8xhwPvb_D8UvvYRL8Q</recordid><startdate>200405</startdate><enddate>200405</enddate><creator>Mydlarski, P R</creator><creator>Mittmann, N</creator><creator>Shear, N H</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>7X8</scope></search><sort><creationdate>200405</creationdate><title>Intravenous immunoglobulin: use in dermatology</title><author>Mydlarski, P R ; Mittmann, N ; Shear, N H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p122t-d6afd8664bb703642cac658a2b3c5c268deae5bbc723a5216101d7f66a3f1c8f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2004</creationdate><topic>Humans</topic><topic>Immunoglobulins, Intravenous - therapeutic use</topic><topic>Skin Diseases - drug therapy</topic><topic>Skin Diseases - immunology</topic><toplevel>online_resources</toplevel><creatorcontrib>Mydlarski, P R</creatorcontrib><creatorcontrib>Mittmann, N</creatorcontrib><creatorcontrib>Shear, N H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>MEDLINE - Academic</collection><jtitle>Skin therapy letter</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mydlarski, P R</au><au>Mittmann, N</au><au>Shear, N H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Intravenous immunoglobulin: use in dermatology</atitle><jtitle>Skin therapy letter</jtitle><addtitle>Skin Therapy Lett</addtitle><date>2004-05</date><risdate>2004</risdate><volume>9</volume><issue>5</issue><spage>1</spage><epage>6</epage><pages>1-6</pages><issn>1201-5989</issn><abstract>A manufactured blood product derived from fractionated human plasma, intravenous immunoglobulin (i.v.Ig) contains supra-physiologic levels of IgG. i.v.Ig is currently used in the treatment of immunodeficiency syndromes, inflammatory disorders and infections diseases. Uncontrolled clinical studies and anecdotal case reports recommend its use in dermatology, but randomized clinical trials are lacking. In selecting the most appropriate i.v.Ig for the patient, convenience, efficacy, safety and tolerability of the different products should be considered. With several measures in place to ensure its safety, i.v.Ig offers new hope for the treatment of many severe dermatologic conditions.</abstract><cop>Canada</cop><pmid>15146260</pmid><tpages>6</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1201-5989
ispartof Skin therapy letter, 2004-05, Vol.9 (5), p.1-6
issn 1201-5989
language eng
recordid cdi_proquest_miscellaneous_71923373
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals
subjects Humans
Immunoglobulins, Intravenous - therapeutic use
Skin Diseases - drug therapy
Skin Diseases - immunology
title Intravenous immunoglobulin: use in dermatology
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-27T03%3A51%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Intravenous%20immunoglobulin:%20use%20in%20dermatology&rft.jtitle=Skin%20therapy%20letter&rft.au=Mydlarski,%20P%20R&rft.date=2004-05&rft.volume=9&rft.issue=5&rft.spage=1&rft.epage=6&rft.pages=1-6&rft.issn=1201-5989&rft_id=info:doi/&rft_dat=%3Cproquest_pubme%3E71923373%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=71923373&rft_id=info:pmid/15146260&rfr_iscdi=true